Breathe Well Live Well
|
Sporadic Steroids May Lessen Asthma Exacerbations For Peds
Monthly Prescribing Reference (registration) HealthDay News — There is strong evidence to support intermittent inhaled corticosteroids (ICS) for prevention of wheeze exacerbations in preschool children with intermittent asthma or viral-triggered wheezing, according to a review published online … |
View full post on asthma – Google News
|
Researchers Find Urine Metabolomics May Act as Asthma Identifier
Monthly Prescribing Reference (registration) HealthDay News — Increased urine metabolomic lipid metabolites are associated with clinical parameters in non-obese asthma patients, according to a study published online May 18 in Allergy. Claudia Chaves Loureiro, MD, PhD, from the Centro Hospitalar … |
View full post on asthma – Google News
Newsmax |
More Exposure to "Sunshine Vitamin" for Mom May Lower Asthma Risk in Kids
Monthly Prescribing Reference (registration) Expecting mothers should make sure they get enough vitamin D exposure during the second trimester to reduce the child's likelihood of developing asthma, according to new research by the University of Kansas published in the American Journal of Health … Getting Sunshine While Pregnant Helps Prevent Asthma in Kids Study Looks at Link Between Vitamin D in Pregnancy and Childhood Asthma |
View full post on asthma – Google News
Monthly Prescribing Reference (registration) |
Adolescent Asthma May Not Be an Allergic Disease
Monthly Prescribing Reference (registration) Asthma for many adolescents should not be considered an allergic disease, a new study published in Respirology suggests. Data on neutrophilic inflammation is well known in adults with non-eosinophilic asthma (NEA); however, not so much is known about … |
View full post on asthma – Google News
|
Overall Increase in Childhood Asthma Ceased, but Not for Poor
Monthly Prescribing Reference (registration) HealthDay News — From 2001 to 2009 there was an increase in childhood asthma prevalence, which plateaued and then started to decline in 2013, according to a study published online Dec. 28 in Pediatrics. Lara J. Akinbami, MD, from the U.S. Centers for … |
View full post on asthma – Google News
|
Omalizumab Highly Effective in Reducing Severe Asthma Symptoms
Monthly Prescribing Reference (registration) Ivo Abraham, PhD, RN, from the University of Arizona in Tucson, and colleagues reviewed 24 real-life effectiveness studies of omalizumab in the treatment of severe allergic asthma. The studies included 4,117 unique patients from 32 countries … |
View full post on asthma – Google News
|
Omalizumab Highly Effective for Severe Allergic Asthma
Monthly Prescribing Reference (registration) Ivo Abraham, PhD, RN, from the University of Arizona in Tucson, and colleagues reviewed 24 real-life effectiveness studies of omalizumab in the treatment of severe allergic asthma. The studies included 4,117 unique patients from 32 countries … |
View full post on asthma – Google News
Monthly Prescribing Reference (registration) |
Asthma Tied to Increased Chronic Migraines
Monthly Prescribing Reference (registration) (HealthDay News) — People with asthma may be more than twice as likely to develop chronic migraines as those without asthma, according to a study published online November 19 in Headache. The research included 4 446 Americans. At the start of the … |
View full post on asthma – Google News
|
Asthma Tied to Increased Risk of Chronic Migraines
Monthly Prescribing Reference (registration) (HealthDay News) — People with asthma may be more than twice as likely to develop chronic migraines as those without asthma, according to a study published online November 19 in Headache. The research included 4 446 Americans. At the start of the … |
View full post on asthma – Google News
Monthly Prescribing Reference (registration) |
Nucala Now Available for Severe Asthma
Monthly Prescribing Reference (registration) GlaxoSmithKline announced the launch of Nucala (mepolizumab) subcutaneous injection for the treatment of patients aged ?12 years with severe asthma with an eosinophilic phenotype. Nucala, the first biologic add-on therapy approved for this condition, … GSK Announces NucalaB. (mepolizumab), Now Available In The Us For Sub-Group Of … GSK Says Nucala Available In U.S. For Sub-group Of Patients With Severe Asthma |
View full post on asthma – Google News